Has Jonathan Schwartz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $823,718 in general payments to Jonathan Schwartz, MD across 662 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Schwartz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Schwartz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Schwartz, MD

Internal Medicine · Charlotte, NCNPI 1790927820

Payments from drug & device makers

$823,718in general payments, 2019–2025

Across 662 payments — averaging $1244.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$520K
Edwards Lifesciences$147K
Medtronic$62K
Boston Scientific$43K
Philips North America LLC$21K
Siemens Medical Solutions USA, Inc.$13K
plus $19K from 12 others

$8,075in research payments, 2019–2025

Across 1 payment — averaging $8075.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$8K

What the payments were for

Consulting fees$83,15143%
Speaking & faculty fees$39,69221%
Grants$1350%
Travel & lodging$46,24324%
Food & beverage$23,97912%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	148	$519,932
Edwards Lifesciences	137	$146,824
Medtronic(2 entities)	187	$62,163
Boston Scientific	111	$42,501
Philips North America LLC	17	$20,690
Siemens Medical Solutions USA, Inc.	27	$12,554
Cardinal Health 200 LLC	10	$8,884
Pi-cardia, Inc.	1	$3,300
W. L. Gore & Associates, Inc.	5	$2,430
Biosense Webster, Inc.	7	$1,490
Opsens Inc.	1	$1,200
Cordis US CORP.	3	$1,184
Heartflow, Inc.	2	$272
Angiodynamics, Inc.	2	$91
Penumbra, Inc.	1	$78
Biotronik Inc.	1	$61
BD	1	$38
Chiesi USA, Inc.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COREVALVE EVOLUT R$32,013
(9520) IGT Devices Undivided$13,163
CoreValve Evolut$11,693
Edwards SAPIEN 3 Transcatheter Heart Valve$11,454
Watchman$10,019
WATCHMAN FLX$9,588
ACUSON SC2000 Diagnostic Ultrasound System$9,320
WATCHMAN Access System$9,095
(9148) ICE 3D$5,200
Shortcut$3,300
GENERAL - THERAPIES$2,850
Mitra Clip system$2,528
Product in Development$2,160
Thermocool SF$1,490
Educ Ultrasound$1,390
SAPIEN 3 Ultra RESILIA$1,355
SavvyWire$1,200
ACUSON Origin Diagnostic Ultrasound System$1,174
MYNX CONTROL$1,125
MitraClip$765

How this compares

$823,718 in reported general payments places this provider in the 95th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina →

Medicare billing

Part B allowed, 2024

$208,216

Medicare patients

358

Services billed

975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	88	$1,128
Atorvastatin Calcium	57	$885
Rosuvastatin Calcium	17	$328
Nitroglycerin	30	$249
Isosorbide Mononitrate ErIsosorbide Mononitrate	17	$197
Metoprolol Succinate	25	$195
Lisinopril	11	$103
Metoprolol Tartrate	19	$73
Carvedilol	15	$56

Paid to pharmacies, not to this prescriber.

Other internal medicine in Charlotte

Saad UsmaniCharlotte$16.2M
Christina KennellyCharlotte$15.4M
Lyndsay MolinariCharlotte$2.4M
Claud GriggCharlotte$1.5M
Maher AghaCharlotte$1M
Marc JohnsonCharlotte$823K
Santosh GopalakrishnanCharlotte$598K
Maithili ChitnavisCharlotte$536K
Christopher FerreriCharlotte$434K
Avinash ShahCharlotte$404K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →